Clinical Outcome of Vinpocetine in Diabetic Nephropathy

Summary

The goal of this controlled, randomized, clinical trial is to evaluate the effect of vinpocetine on clinical outcomes on the diabetic nephropathy patients. The following will be evaluated; anthropometrics, kidney functions, glucose panel, lipid panel, ICAM-1, quality of life. Participants will receive either vinpocetine or placebo, twice daily for 3 months.

Timeline

Start

2024-07-10

Primary completion

2025-06-01

Completion

2025-06-01

Drugs

Indications